New target for treating “undruggable” lung cancer
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
MIT alumnus and two others honored for discovering the molecular mechanisms of circadian rhythms.
Cutting off a process that cancerous cells rely on can force them to stop growing.
Professor of chemistry is the first woman to win the prestigious prize, awarded annually for creativity in organic chemistry or bioorganic and medicinal chemistry.
Former Whitehead Fellow and recent International Space Station resident gives public talk and engages with the next generation of scientists and engineers.
Graham Walker, Michael Yaffe, and Robert Weinberg earn support from the National Institutes of Health to further their research endeavors.
Assistant professors Joey Davis and Rebecca Lamason will spearhead research initiatives into fundamental cellular processes.
In study that may guide drug design, researchers find organelles encounter varying levels of resistance.
A pioneer in the field of intermediary metabolism and former dean of the School of Science, Brown’s deepest passion was teaching.
Researchers gauge a cell’s stiffness, which can reflect cancer or other conditions, simply by watching it.
Recent additions bring diverse expertise and cultural perspectives to research community.
Results may help surgeons determine when and how to treat heart attacks.
Emily Havens Greenhagen ’05 leads a team of scientists brewing perfume from yeast.
Seven award-winning faculty members represent the departments of Physics, Chemistry, and Biology.
Entrepreneurs, researchers, and industry experts build connections at workshop.